06.18.18
FDA Approves the Next Generation of Customized LASIK Treatment with iDESIGN Refractive Studio
Source: Johnson & Johnson Vision
Johnson & Johnson Vision announced today the FDA approval of the iDESIGN Refractive Studio, making it the only system to use topography-integrated, wavefront-guided technology. This allows doctors to take a precise measurement of the eye inside and out to deliver a LASIK procedure personalized to the individual patient, according to Johnson & Johnson Vision.
The iDESIGN is approved for myopia, hyperopia, and mixed astigmatism, and is the only available LASIK platform indicated for monovision LASIK in presbyopic myopic patients.
“As a practicing ophthalmologist for more than 25 years, I know firsthand the importance of taking precise measurements and tailoring LASIK procedures for each
Read Article
Featured Stories
06.15.18
American Academy of Ophthalmology Reiterates Long-Standing Guidance on LASIK Patient Education
Source: American Academy of Ophthalmology
06.13.18
Allergan Announces Positive Topline Phase 3 Clinical Data for Bimatoprost SR Implant
Source: Allergan
06.12.18
Source: GenSight Biologics
Latest News
06.18.18
Bausch + Lomb Receives FDA Pre-Market Approval for Envista Toric MX60T IOLSource: Bausch + Lomb
06.18.18
Avedro Announces Enrollment of First Patient in Phase 3 Epi-On Corneal Cross-Linking TrialSource: Avedro
06.15.18
Alcon to Showcase New Products, Commitment to ECP Education at 2018 Optometry’s MeetingSource: Alcon
06.15.18
Foundation Fighting Blindness Launches the Stargardt Disease Natural History StudySource: Foundation Fighting Blindness
06.15.18
Allergan Announces Former Abbott Executive to Join Board of Directors as Part of “Refreshment Process”Source: FirstWord
06.14.18
Bausch + Lomb Launches Soothe Xtra Protection Preservative Free Lubricant Eye DropsSource: Bausch + Lomb
06.14.18
“Dr. Robert Ritch Forum on Medicine of the Future” at World Ophthalmology Congress 2018Source: New York Eye and Ear Infirmary of Mount Sinai
06.14.18
Researchers Find Novel Structure in the ‘Antennae’ of Light-Sensing NeuronsSource: Baylor College of Medicine
06.14.18
Clearside Biomedical Announces Completion of Patient Enrollment in Phase 3 Clinical Trial of CLS-TA in RVOSource: Clearside Biomedical
